
NanoInk, Inc.
NanoInk, Inc. is an emerging growth technology company specializing in nanometer-scale manufacturing and application development for the life science and semiconductor industries. With DPN®, a patented and proprietary nanofabrication technology that allows for unmatched flexibility and accuracy, and high-resolution Nanoencryption™ technology, NanoInk is able to offer customers innovative solutions to fight counterfeiting and illegal diversion of products. Other key applications include nanoscale additive repair and nanoscale rapid prototyping. Located in the new Illinois Science and Technology Park north of Chicago, NanoInk currently has over 100 issued or pending patents and patent applications filed worldwide and has licensing agreements with Northwestern University, Stanford University, the University of Illinois at Urbana-Champaign and the Georgia Institute of Technology.
Nanoencryption technology is a layered pharmaceutical brand protection solution based on proprietary nanolithographic encryption technology. While overt techniques exist, and provide easy field identification, overt technologies alone can't protect a brand. If counterfeiters can see a label, they will defeat it. Nanoencryption technology incorporates semi-overt, covert and nanoscale forensic features at the unit dose level which can also be linked to the package level for a multi-layered protective shield.